Delivery Order SPE2DB22D2009-SPE2DB25FL9MZ
- Not listed
- The Defense Logistics Agency awarded a $3,655.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on June 6, 2025, with completion scheduled for June 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $19,742.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $6,972.88 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $21,080.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,193.61 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) with a firm fixed price structure and an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $20,762.85 delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (quantity: 8 units) under a firm fixed-price contract. This non-set-aside award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8-pack quantity) valued at $14,310.29 under a firm fixed price contract. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FL9MZDelivery Order
The Defense Logistics Agency awarded a $5,211.52 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical distributor's role in supplying specialized therapeutic medications to support military and federal healthcare systems. This delivery order is part of AmerisourceBergen's broader engagement with the Defense Logistics Agency's medical supply chain, where the company holds a substantial $999,999,999.00 indefinite delivery vehicle through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic categories to support Department of Defense health programs and other federal healthcare entities. The company's contract portfolio with DLA demonstrates consistent capability to fulfill federal medical procurement requirements across transactions ranging from small orders to substantial multi-million dollar commitments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 6/3/25 |